03068nas a2200337 4500000000100000008004100001260002500042653001400067653002800081653002200109653001900131653001900150653002600169100002300195700002400218700002300242700002000265700002200285700002100307700001400328700002100342700002400363700002100387700002500408700002500433245011700458856008000575300001100655520205000666022001402716 2026 d c09/2026bElsevier BV10aPregnancy10aCongenital transmission10aTrypanosoma cruzi10aChagas disease10aAchondroplasia10aLeukoencephalomalacia1 aVillamil-Gómez WE1 aBarahona-Escobar GE1 aMoisa-Martínez MA1 aPeña-Navarro D1 aPaniagua-Rojas LV1 aRincones-Soto DE1 aBarcha ML1 aOchoa-Salcedo Á1 aÁlvarez-Mon Soto M1 aEyes-Escalante M1 aVenegas-Hermosilla J1 aRodriguez-Morales AJ00aChagas Disease Across Pregnancy and Early Infancy: Leukoencephalomalacia and Achondroplasia in Two Unusual Cases uhttps://regions.ijidonline.org/action/showPdf?pii=S2772-7076%2826%2900179-7 a1 - 133 a
Congenital Chagas disease remains an underdiagnosed cause of neonatal morbidity and mortality in endemic regions. Although most infected neonates are asymptomatic or present with nonspecific findings, severe and atypical manifestations involving the central nervous system or coexistence with genetic disorders are rarely reported. The full spectrum of neurological injury and potential interactions between Trypanosoma cruzi infection and fetal developmental conditions remain poorly characterized.
We report two unusual clinical presentations of T. cruzi infection during early infancy and pregnancy from El Salvador and Colombia. The first case involved a 2-month-old female infant who presented with septic shock, acute kidney injury, coagulopathy, and respiratory failure. Direct parasitological examination revealed circulating T. cruzi trypomastigotes, confirming acute Chagas disease; however, the route of transmission could not be definitively established. Despite a favorable parasitological response to nifurtimox, brain magnetic resonance imaging subsequently demonstrated bilateral cystic leukoencephalomalacia and widespread ischemic sequelae, interpreted as secondary hypoxic–ischemic injury following the severe systemic illness. The second case involved a pregnant woman with confirmed T. cruzi infection whose fetus was prenatally diagnosed with achondroplasia. The neonate developed severe respiratory failure and died 10 days after birth. No alternative infectious or metabolic causes explaining the skeletal dysplasia or fatal outcome were identified.
These cases highlight unusual presentations of T. cruzi infection during early infancy and pregnancy, including severe systemic disease followed by hypoxic–ischemic neurological sequelae and coexistence with fetal achondroplasia. They underscore the importance of maternal screening and systematic evaluation of exposed neonates.
a2772-7076